ABSI
HEALTHCAREAbsci Corp
Live · NASDAQ · May 9, Close
What's Moving ABSI Today?
No stock-specific AI insight has been generated for ABSI yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$5.95
Fundamentals
Trading
ABSI News
20 articles- Absci Corporation (ABSI) Reports Q1 Loss, Misses Revenue EstimatesYahoo Finance·May 8, 2026
- Absci (ABSI) Q1 2026 Earnings Call TranscriptMotley Fool·May 7, 2026
- Absci Q1 Earnings Call HighlightsMarketbeat·May 7, 2026
- Absci Reports Business Updates and First Quarter 2026 Financial and Operating ResultsYahoo Finance·May 7, 2026
- Recursion Pharmaceuticals Q1 Earnings Call HighlightsMarketbeat·May 6, 2026
- Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)Yahoo Finance·May 5, 2026
- Here is Why Absci Corp. (ABSI) is One of the Best Biotech Penny Stocks to Buy in 2026Yahoo Finance·May 1, 2026
- Absci Corp. (ABSI) Offering Impressive Upside to Potential InvestorsYahoo Finance·Apr 26, 2026
- Absci to Report Business Updates and First Quarter 2026 Financial and Operating Results on May 7, 2026Yahoo Finance·Apr 23, 2026
- Absci Highlights AI Antibody Platform, Teases ABS-201 Hair-Loss Data and 2026 Milestones at Needham ConferenceMarketbeat·Apr 16, 2026
- Absci to Participate in the 25th Annual Needham Virtual Healthcare ConferenceYahoo Finance·Apr 8, 2026
- Here's Why We're Watching Absci's (NASDAQ:ABSI) Cash Burn SituationYahoo Finance·Mar 26, 2026
- Absci (ABSI) Q4 2025 Earnings Call TranscriptMotley Fool·Mar 25, 2026
- Absci Corporation Q4 2025 Earnings Call SummaryMoby·Mar 25, 2026
- Absci Corp (ABSI) Q4 2025 Earnings Call Highlights: Strategic Advances and Financial ResilienceYahoo Finance·Mar 25, 2026
- Absci Q4 Earnings Call HighlightsMarketbeat·Mar 24, 2026
- Absci Corporation (ABSI) Reports Q4 Loss, Misses Revenue EstimatesYahoo Finance·Mar 24, 2026
- Absci Reports Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating ResultsYahoo Finance·Mar 24, 2026
- Absci Launches ABS-201 Endometriosis Advisory Board with Leading Experts from Yale, UCSF, Duke, and the Mayo ClinicYahoo Finance·Mar 24, 2026
- InflaRx N.V. (IFRX) Reports Q4 Loss, Lags Revenue EstimatesYahoo Finance·Mar 19, 2026
All 20 articles loaded
Price Data
52-Week Range
$5.95
Fundamentals
Trading
About Absci Corp
Absci Corp (ABSI) is an innovative biotechnology firm that leverages its advanced AI-driven biology platform to transform the drug discovery process. By enabling the rapid generation of high-quality proteins and therapeutic candidates, Absci minimizes development timelines and reduces costs, positioning itself as a leader in the biopharmaceutical sector. The company partners with various stakeholders to develop and manufacture next-generation therapies, emphasizing efficiency and precision. With a strong pipeline of collaborations and proprietary programs, Absci is set to make impactful contributions to modern medicine and the treatment of diseases.